Molecular‐targeted first‐line therapy for advanced gastric cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Molecular‐targeted First‐line Therapy for Advanced Gastric Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer. Accessed 28 September 2023.
Molecular‐targeted first‐line therapy for advanced gastric cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer. Accessed September 28, 2023.
Molecular‐targeted first‐line therapy for advanced gastric cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer
Molecular‐targeted First‐line Therapy for Advanced Gastric Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 September 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Molecular‐targeted first‐line therapy for advanced gastric cancer
ID - 434113
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -